Proto Labs (PRLB) Stock Forecast, Price Target & Predictions
PRLB Stock Forecast
Proto Labs stock forecast is as follows: an average price target of $38.50 (represents a 29.50% upside from PRLB’s last price of $29.73) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
PRLB Price Target
The average price target for Proto Labs (PRLB) is $38.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $44.00 to $34.00. This represents a potential 29.50% upside from PRLB's last price of $29.73.
PRLB Analyst Ratings
According to 3 Wall Street analysts, Proto Labs's rating consensus is 'Buy'. The analyst rating breakdown for PRLB stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Proto Labs Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 05, 2024 | Troy Jensen | Cantor Fitzgerald | $44.00 | $30.32 | 45.12% | 48.00% |
| May 06, 2024 | Greg Palm | Craig-Hallum | $34.00 | $31.02 | 9.59% | 14.36% |
| Feb 02, 2023 | - | Lake Street | $37.50 | $33.33 | 12.51% | 26.14% |
| Nov 29, 2022 | - | Lake Street | $29.00 | $25.48 | 13.81% | -2.46% |
| Nov 04, 2022 | Greg Palm | Craig-Hallum | $20.00 | $25.55 | -21.72% | -32.73% |
The latest Proto Labs stock forecast, released on Jun 05, 2024 by Troy Jensen from Cantor Fitzgerald, set a price target of $44.00, which represents a 45.12% increase from the stock price at the time of the forecast ($30.32), and a 48.00% increase from PRLB last price ($29.73).
Proto Labs Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $39.00 |
| Last Closing Price | $29.73 | $29.73 | $29.73 |
| Upside/Downside | -100.00% | -100.00% | 31.18% |
In the current month, the average price target of Proto Labs stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Proto Labs's last price of $29.73. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 30, 2024 | Cantor Fitzgerald | Underperform | Underperform | Hold |
| Jul 30, 2024 | Craig-Hallum | Buy | Buy | Hold |
| Jun 05, 2024 | Cantor Fitzgerald | - | Overweight | Initialise |
| May 06, 2024 | Craig-Hallum | Hold | Hold | Hold |
| Aug 04, 2023 | Craig-Hallum | - | Hold | Upgrade |
| Feb 13, 2023 | Benchmark | - | Positive | Upgrade |
| Feb 02, 2023 | Lake Street | Buy | Buy | Hold |
| Nov 29, 2022 | Lake Street | - | Buy | Initialise |
Proto Labs's last stock rating was published by Cantor Fitzgerald on Jul 30, 2024. The company gave PRLB a "Underperform" rating, the same as its previous rate.
Proto Labs Financial Forecast
Proto Labs Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $125.05M | $130.71M | $122.27M | $125.86M | $115.61M | $121.72M | - | $124.17M | $123.58M | $125.34M | $123.05M | $116.13M | $105.21M | $107.50M | $106.58M | $115.11M | $111.89M | $117.45M | $115.93M | $113.45M | $112.77M | $115.43M |
| Avg Forecast | $130.06M | $130.20M | $127.46M | $124.23M | $120.01M | $121.38M | $126.25M | $125.53M | $122.81M | $123.08M | $123.88M | $119.40M | $110.83M | $126.05M | $127.92M | $122.89M | $118.72M | $128.13M | $122.36M | $113.91M | $103.16M | $105.66M | $100.46M | $102.36M | $112.15M | $119.42M | $116.49M | $115.24M | $121.95M | $99.30M |
| High Forecast | $131.48M | $131.62M | $128.84M | $125.58M | $121.31M | $122.70M | $127.62M | $126.89M | $124.15M | $124.11M | $125.23M | $120.70M | $112.03M | $127.42M | $127.92M | $123.68M | $119.49M | $128.95M | $123.14M | $114.64M | $103.82M | $106.34M | $101.10M | $103.01M | $112.87M | $120.18M | $117.23M | $115.98M | $146.34M | $119.16M |
| Low Forecast | $129.20M | $129.33M | $126.61M | $123.40M | $119.20M | $120.57M | $125.40M | $124.69M | $121.99M | $122.31M | $123.06M | $118.61M | $110.09M | $125.21M | $127.92M | $122.59M | $118.43M | $127.82M | $122.06M | $113.63M | $102.90M | $105.40M | $100.21M | $102.11M | $111.88M | $119.12M | $116.20M | $114.96M | $97.56M | $79.44M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | - | 1 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 11 | 12 | 16 | 9 | 9 | 8 | 9 | 13 | 17 | 19 | 15 |
| Surprise % | - | - | - | - | - | - | - | - | 1.02% | 1.06% | 0.99% | 1.05% | 1.04% | 0.97% | - | 1.01% | 1.04% | 0.98% | 1.01% | 1.02% | 1.02% | 1.02% | 1.06% | 1.12% | 1.00% | 0.98% | 1.00% | 0.98% | 0.92% | 1.16% |
Proto Labs's average Quarter revenue forecast for Mar 24 based on 0 analysts is $125.53M, with a low forecast of $124.69M, and a high forecast of $126.89M. PRLB's average Quarter revenue forecast represents a 0.38% increase compared to the company's last Quarter revenue of $125.05M (Dec 23).
Proto Labs EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | - | 1 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 11 | 12 | 16 | 9 | 9 | 8 | 9 | 13 | 17 | 19 | 15 |
| EBITDA | - | - | - | - | - | - | - | - | $8.39M | $10.41M | $5.61M | $13.27M | $119.95M | $18.15M | - | $18.42M | $23.19M | $17.17M | $26.31M | $14.01M | $20.25M | $26.43M | $23.02M | $25.84M | $27.54M | $29.18M | $28.24M | $27.10M | $28.77M | $32.19M |
| Avg Forecast | $27.76M | $27.79M | $27.21M | $26.52M | $25.62M | $25.91M | $26.95M | $19.67M | $26.22M | $26.27M | $26.44M | $15.55M | $23.66M | $22.40M | $27.31M | $12.29M | $15.94M | $20.36M | $14.00M | $14.01M | $19.84M | $18.81M | $20.28M | $11.22M | $27.54M | $28.39M | $27.84M | $27.10M | $30.93M | $26.97M |
| High Forecast | $28.07M | $28.10M | $27.50M | $26.81M | $25.90M | $26.19M | $27.24M | $23.60M | $26.50M | $26.49M | $26.73M | $18.66M | $23.92M | $26.88M | $27.31M | $14.75M | $19.13M | $24.43M | $16.80M | $16.81M | $23.81M | $22.57M | $24.33M | $13.46M | $33.05M | $34.07M | $33.40M | $32.52M | $37.11M | $32.37M |
| Low Forecast | $27.58M | $27.61M | $27.03M | $26.34M | $25.45M | $25.74M | $26.77M | $15.73M | $26.04M | $26.11M | $26.27M | $12.44M | $23.50M | $17.92M | $27.31M | $9.83M | $12.75M | $16.29M | $11.20M | $11.21M | $15.87M | $15.05M | $16.22M | $8.97M | $22.03M | $22.71M | $22.27M | $21.68M | $24.74M | $21.58M |
| Surprise % | - | - | - | - | - | - | - | - | 0.32% | 0.40% | 0.21% | 0.85% | 5.07% | 0.81% | - | 1.50% | 1.45% | 0.84% | 1.88% | 1.00% | 1.02% | 1.41% | 1.13% | 2.30% | 1.00% | 1.03% | 1.01% | 1.00% | 0.93% | 1.19% |
0 analysts predict PRLB's average Quarter EBITDA for Mar 24 to be $19.67M, with a high of $23.60M and a low of $15.73M. This is 134.29% upper than Proto Labs's previous annual EBITDA (Dec 23) of $8.39M.
Proto Labs Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | - | 1 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 11 | 12 | 16 | 9 | 9 | 8 | 9 | 13 | 17 | 19 | 15 |
| Net Income | - | - | - | - | - | - | - | - | $6.99M | $7.95M | $-383.00K | $2.66M | $-115.06M | $3.95M | - | $5.09M | $11.91M | $4.83M | $12.91M | $3.71M | $9.58M | $14.70M | $12.61M | $13.98M | $15.19M | $16.79M | $16.17M | $15.51M | $19.29M | $20.94M |
| Avg Forecast | $9.22M | $9.73M | $9.05M | $8.12M | $7.46M | $8.17M | $8.79M | $5.62M | $8.12M | $8.08M | $7.58M | $4.44M | $5.69M | $6.31M | $10.11M | $3.51M | $8.19M | $5.73M | $6.87M | $3.71M | $9.38M | $10.46M | $11.11M | $6.07M | $15.19M | $16.34M | $15.94M | $15.51M | $20.73M | $17.54M |
| High Forecast | $9.35M | $9.86M | $9.18M | $8.23M | $7.57M | $8.29M | $8.92M | $6.75M | $8.23M | $8.19M | $7.68M | $5.33M | $5.77M | $7.57M | $10.11M | $4.22M | $9.83M | $6.88M | $8.25M | $4.45M | $11.26M | $12.55M | $13.33M | $7.29M | $18.22M | $19.61M | $19.12M | $18.61M | $24.88M | $21.05M |
| Low Forecast | $9.14M | $9.64M | $8.97M | $8.05M | $7.39M | $8.10M | $8.72M | $4.50M | $8.05M | $7.81M | $7.51M | $3.56M | $5.64M | $5.05M | $10.11M | $2.81M | $6.55M | $4.59M | $5.50M | $2.97M | $7.51M | $8.37M | $8.89M | $4.86M | $12.15M | $13.07M | $12.75M | $12.41M | $16.59M | $14.03M |
| Surprise % | - | - | - | - | - | - | - | - | 0.86% | 0.98% | -0.05% | 0.60% | -20.22% | 0.63% | - | 1.45% | 1.45% | 0.84% | 1.88% | 1.00% | 1.02% | 1.41% | 1.13% | 2.30% | 1.00% | 1.03% | 1.01% | 1.00% | 0.93% | 1.19% |
Proto Labs's average Quarter net income forecast for Mar 24 is $5.62M, with a range of $4.50M to $6.75M. PRLB's average Quarter net income forecast represents a -19.56% decrease compared to the company's last Quarter net income of $6.99M (Dec 23).
Proto Labs SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | - | 1 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 11 | 12 | 16 | 9 | 9 | 8 | 9 | 13 | 17 | 19 | 15 |
| SG&A | - | - | - | - | - | - | - | - | $37.90M | $38.74M | $37.55M | $39.28M | $38.29M | $37.07M | - | $37.36M | $31.98M | $37.78M | $29.46M | $38.89M | $30.25M | $29.06M | $29.46M | $32.29M | $28.86M | $29.98M | $32.49M | $31.40M | $31.42M | $29.91M |
| Avg Forecast | $37.50M | $37.54M | $36.75M | $35.82M | $34.60M | $34.99M | $36.40M | $41.23M | $35.41M | $35.48M | $35.72M | $32.59M | $31.95M | $49.29M | $36.88M | $25.76M | $21.98M | $44.81M | $15.68M | $38.89M | $29.63M | $20.68M | $25.96M | $14.02M | $28.86M | $29.17M | $32.03M | $31.40M | $33.78M | $25.06M |
| High Forecast | $37.91M | $37.95M | $37.15M | $36.20M | $34.97M | $35.38M | $36.79M | $49.47M | $35.79M | $35.78M | $36.10M | $39.11M | $32.30M | $59.15M | $36.88M | $30.92M | $26.38M | $53.77M | $18.82M | $46.67M | $35.56M | $24.81M | $31.15M | $16.82M | $34.64M | $35.01M | $38.44M | $37.68M | $40.53M | $30.08M |
| Low Forecast | $37.25M | $37.29M | $36.50M | $35.58M | $34.37M | $34.76M | $36.15M | $32.98M | $35.17M | $35.26M | $35.48M | $26.07M | $31.74M | $39.43M | $36.88M | $20.61M | $17.59M | $35.85M | $12.54M | $31.11M | $23.70M | $16.54M | $20.76M | $11.22M | $23.09M | $23.34M | $25.62M | $25.12M | $27.02M | $20.05M |
| Surprise % | - | - | - | - | - | - | - | - | 1.07% | 1.09% | 1.05% | 1.21% | 1.20% | 0.75% | - | 1.45% | 1.45% | 0.84% | 1.88% | 1.00% | 1.02% | 1.41% | 1.13% | 2.30% | 1.00% | 1.03% | 1.01% | 1.00% | 0.93% | 1.19% |
Proto Labs's average Quarter SG&A projection for Mar 24 is $41.23M, based on 0 Wall Street analysts, with a range of $32.98M to $49.47M. The forecast indicates a 8.78% rise compared to PRLB last annual SG&A of $37.90M (Dec 23).
Proto Labs EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | - | 1 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 11 | 12 | 16 | 9 | 9 | 8 | 9 | 13 | 17 | 19 | 15 |
| EPS | - | - | - | - | - | - | - | - | $0.27 | $0.31 | $-0.01 | $0.10 | $-4.24 | $0.14 | - | $0.19 | $0.43 | $0.17 | $0.47 | $0.14 | $0.36 | $0.55 | $0.47 | $0.52 | $0.57 | $0.63 | $0.60 | $0.58 | $0.71 | $0.77 |
| Avg Forecast | $0.36 | $0.38 | $0.36 | $0.32 | $0.29 | $0.32 | $0.35 | $0.32 | $0.32 | $0.32 | $0.30 | $0.23 | $0.22 | $0.40 | $0.39 | $0.28 | $0.27 | $0.43 | $0.44 | $0.42 | $0.51 | $0.55 | $0.36 | $0.38 | $0.63 | $0.74 | $0.70 | $0.69 | $0.86 | $0.62 |
| High Forecast | $0.37 | $0.39 | $0.36 | $0.32 | $0.30 | $0.33 | $0.35 | $0.33 | $0.32 | $0.32 | $0.30 | $0.23 | $0.23 | $0.40 | $0.39 | $0.29 | $0.28 | $0.43 | $0.45 | $0.42 | $0.51 | $0.55 | $0.37 | $0.38 | $0.63 | $0.75 | $0.70 | $0.70 | $1.03 | $0.74 |
| Low Forecast | $0.36 | $0.38 | $0.35 | $0.32 | $0.29 | $0.32 | $0.34 | $0.32 | $0.32 | $0.31 | $0.30 | $0.23 | $0.22 | $0.39 | $0.39 | $0.28 | $0.27 | $0.42 | $0.44 | $0.42 | $0.51 | $0.55 | $0.36 | $0.37 | $0.62 | $0.74 | $0.70 | $0.69 | $0.69 | $0.50 |
| Surprise % | - | - | - | - | - | - | - | - | 0.84% | 0.97% | -0.05% | 0.43% | -18.90% | 0.35% | - | 0.67% | 1.57% | 0.40% | 1.06% | 0.33% | 0.71% | 1.01% | 1.29% | 1.38% | 0.91% | 0.85% | 0.86% | 0.84% | 0.83% | 1.24% |
According to 0 Wall Street analysts, Proto Labs's projected average Quarter EPS for Mar 24 is $0.32, with a low estimate of $0.32 and a high estimate of $0.33. This represents a 20.13% increase compared to PRLB previous annual EPS of $0.27 (Dec 23).
Proto Labs Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| RYI | Ryerson | $19.30 | $36.50 | 89.12% | Hold |
| PRLB | Proto Labs | $29.73 | $38.50 | 29.50% | Buy |
| MEC | Mayville Engineering Company | $19.56 | $24.00 | 22.70% | Buy |
| WOR | Worthington Industries | $45.70 | $52.00 | 13.79% | Hold |
| ESAB | ESAB | $103.81 | $115.00 | 10.78% | Buy |
| ATI | ATI | $61.84 | $64.00 | 3.49% | Buy |
| CRS | Carpenter | $143.31 | $144.00 | 0.48% | Buy |
PRLB Forecast FAQ
Is Proto Labs a good buy?
Yes, according to 3 Wall Street analysts, Proto Labs (PRLB) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of PRLB's total ratings.
What is PRLB's price target?
Proto Labs (PRLB) average price target is $38.5 with a range of $34 to $44, implying a 29.50% from its last price of $29.73. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Proto Labs stock go up soon?
According to Wall Street analysts' prediction for PRLB stock, the company can go up by 29.50% (from the last price of $29.73 to the average price target of $38.5), up by 48.00% based on the highest stock price target, and up by 14.36% based on the lowest stock price target.
Can Proto Labs stock reach $40?
PRLB's highest twelve months analyst stock price target of $44 supports the claim that Proto Labs can reach $40 in the near future.
What are Proto Labs's analysts' financial forecasts?
Proto Labs's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $493.16M (high $498.52M, low $489.87M), average EBITDA is $98.15M (high $102.93M, low $93.69M), average net income is $30.05M (high $31.52M, low $28.71M), average SG&A $147.22M (high $156.61M, low $138.26M), and average EPS is $1.29 (high $1.31, low $1.28). PRLB's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $511.95M (high $517.52M, low $508.54M), average EBITDA is $109.29M (high $110.47M, low $108.56M), average net income is $36.11M (high $36.62M, low $35.8M), average SG&A $147.6M (high $149.2M, low $146.61M), and average EPS is $1.42 (high $1.44, low $1.41).
Did the PRLB's actual financial results beat the analysts' financial forecasts?
Based on Proto Labs's last annual report (Dec 2023), the company's revenue was $503.88M, beating the average analysts forecast of $489.18M by 3.00%. Apple's EBITDA was $28.17M, missing the average prediction of $94.48M by -70.19%. The company's net income was $17.22M, missing the average estimation of $28.22M by -38.98%. Apple's SG&A was $153.48M, beating the average forecast of $139.2M by 10.26%. Lastly, the company's EPS was $0.66, missing the average prediction of $1.17 by -43.52%. In terms of the last quarterly report (Dec 2023), Proto Labs's revenue was $125.05M, beating the average analysts' forecast of $122.81M by 1.82%. The company's EBITDA was $8.4M, missing the average prediction of $26.22M by -67.98%. Proto Labs's net income was $6.99M, missing the average estimation of $8.12M by -13.91%. The company's SG&A was $37.9M, beating the average forecast of $35.41M by 7.04%. Lastly, the company's EPS was $0.27, missing the average prediction of $0.32 by -15.62%